Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... और पढ़ें
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... और पढ़ें
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and ... और पढ़ें
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In ... और पढ़ें
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopha... और पढ़ें
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804563) titled 'Recreational Football for Young-to-middle-aged Inactive Men' on Aug. 31. Brief Summary: Th... और पढ़ें
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 ... और पढ़ें
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804186) titled 'Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic U... और पढ़ें
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Clinical and Economic Outcomes of Adding Semaglutide to Standard of Care in Adult P... और पढ़ें
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination with Int... और पढ़ें